Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 10

PHARMACOVIGILANCE

Pharmacovigilance
The science and activities relating to the
detection, assessment, understanding, and
prevention of adverse effects or any other drug-
related problem.
Aim:
• To improve patient care and safety in relation to the use of medicines
• To contribute to the assessment of benefit, harm, effectiveness 
• Track serious adverse events
• Educate on drug safety
Difference between ADR and AE

• ADR is associated with a causational relationship between the


medication and the injury.

• Within AEs, such events are viewed as side effects and causative
relationships between a drug and the event cannot be established.
AEs can also be related to medical procedures.
several facets of AE reporting:

• Individual Case Safety Report.


• Expedited reporting.
• Clinical trial reporting.
• Spontaneous reporting.
• Aggregate reporting.
Regulatory authorities

• United States – FDA : Food and Drug Administration


• European Union - European Medicines Agency
• Canada -Health Canada
•  India- CDSCO : Central Drugs Standard Control Organization 
• UK- MHRA: Medicines and Healthcare products Regulatory Agency 
softwares used in pharmacovigilance are:

• Oracle Argus Safety.


• ArisG.
• Oracle Adverse Event Reporting System (AERS)
• ClinTrace.
• PvNET.
• repClinical.
• Vigilanz Dynamic Monitoring System.
• WebVDME Pharmacovigilance Signal detection and Signal management
software.
Yellow Card scheme

• UK system for collecting information on suspected adverse drug


interactions to medicines and vaccines.
• Created in 1964, after the Thalidomide tragedy.
• It is run by the Medicines Control Agency on behalf of the Committee
on Safety of Medicines.
• Anyone can report a Yellow Card, from healthcare professionals to
members of the public. 
VigiBase
• WHO's global database of reported potential side effects of medicinal
products, is regularly screened for possible safety signals requiring
further investigation and action to prevent harm to patients.
• According to the WHO-UMC definition, a safety signal refers
to information on a new or known side effect that may be caused by a
medicine and is typically generated from more than a single report of
a suspected side effect.
3 types of signals
• 1.confirmed signals-causal relationship between the drug and adverse
event
• 2.refuted(false) signals-no causal relationship
• 3.unconfirmed signals-require further investigation

You might also like